Consequently, molecular‐level understanding of gangliosides interaction with Siglec‐7 can not only shed light on the mechanisms underlying immune evasion in cancer, but also help the development of targeted strategies to modulate these interactions. This evidence concerns the gene SIGLEC7 and cancer.